July 28th, 2014
Today is World Hepatitis Day, one of only four disease-related awareness days officially endorsed by the World Health Organization (WHO). This year’s theme is ‘Think Again’, calling upon policy-makers, health workers and the public to re-think viral hepatitis.
It’s a critically important day because more than 500 million people, many unknowingly, are affected by viral hepatitis globally. And more so for us here in Asia Pacific where recent data showed that 70% of the 1.4 million annual global deaths associated with the disease occur.
It’s why the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) launched the ‘One Million Lives Lost’ social media campaign last year – drawing attention to the fact that every 30 seconds, one person dies from these devastating diseases in Asia Pacific countries.
Driven by our commitment to patients, we have developed some of the first new medicines for hepatitis C in nearly a decade. These are today positively impacting thousands of patients affected by hepatitis C. But we don’t stop there. We want to further transform how viral hepatitis is treated. This is why we maintain a strong and robust research program in both hepatitis B and C.